2020
DOI: 10.3390/genes11101127
|View full text |Cite
|
Sign up to set email alerts
|

Parallelized Latent Dirichlet Allocation Provides a Novel Interpretability of Mutation Signatures in Cancer Genomes

Abstract: Mutation signatures are defined as the distribution of specific mutations such as activity of AID/APOBEC family proteins. Previous studies have reported numerous signatures, using matrix factorization methods for mutation catalogs. Different mutation signatures are active in different tumor types; hence, signature activity varies greatly among tumor types and becomes sparse. Because of this, many previous methods require dividing mutation catalogs for each tumor type. Here, we propose parallelized latent Diric… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…In this study, the model of the Latent Dirichlet Allocation (LDA) command in STATA was applied. The LDA is a familiar and helpful method for topic classification modeling into a group of similar topics [ 38 ]. It can separate the collected scientific research as “discrete distributions over latent topics”; each topic can perform as a “discrete distribution over all the terms”.…”
Section: Methodsmentioning
confidence: 99%
“…In this study, the model of the Latent Dirichlet Allocation (LDA) command in STATA was applied. The LDA is a familiar and helpful method for topic classification modeling into a group of similar topics [ 38 ]. It can separate the collected scientific research as “discrete distributions over latent topics”; each topic can perform as a “discrete distribution over all the terms”.…”
Section: Methodsmentioning
confidence: 99%
“…Besides, SigTracer prepares Dirichlet distributions as conjugate priors for the signature activity of each clone. This extension can be regarded as a generalization of the CloneSig model, and other studies on similar tasks such as signature extraction have already highlighted the effectiveness of Dirichlet priors [14,15,16]. Here, we aimed to show if SigTracer provides more reasonable clone estimations than CloneSig for artificial tumors.…”
Section: Introductionmentioning
confidence: 99%